文献速递乳腺乳腺X线

合成断层融合与全视野数字乳腺X线摄影筛查中初始发现钙化的诊断结局是否存在差异

Is There a Difference in the Diagnostic Outcomes of Calcifications Initially Identified on Synthetic Tomosynthesis Versus Full-Field Digital Mammography Screening?
PubMed 文献 · Eur J Radiol · 2020-10-26

本研究回顾性比较了合成断层融合(SM)与全视野数字乳腺X线摄影(FFDM)及联合断层融合(Combo)筛查中因钙化召回后的诊断结局。SM组钙化在诊断性检查中未验证率更高(0.8% vs 10%,p<0.0001),活检恶性比例更高(36% vs 22%,OR 0.5,95%CI 0.3-0.8,p=0.01),但最终良恶性结局无差异(17% vs 13%,OR 0.8,95%CI 0.5-1.2,p=0.27)。结论认为合成断层融合筛查导致更高的假阳性和未验证钙化召回率。

要点

  • SM筛查钙化在诊断性检查中未验证率高于FFDM/Combo(0.8% vs 10%,p<0.0001)。
  • SM组钙化诊断性检查时BI-RADS 2/3比例高于FFDM/Combo(55% vs 42%,p=0.003)。
  • 活检恶性比例SM组36% vs FFDM/Combo组22%,OR 0.5(95%CI 0.3-0.8),p=0.01。

核心结论

  • 合成断层融合筛查相比FFDM/Combo导致更高的假阳性和未验证钙化召回率,但最终良恶性结局无显著差异。

研究设计与样本

  • 回顾性研究,纳入2016年11月1日至2018年11月1日在本机构乳腺X线筛查中因异常钙化需进一步评估的患者,共596名女性699个钙化;比较SM、FFDM和Combo三种筛查技术,以活检病理或至少1年影像随访确立最终诊断结局。

关键影像表现/征象

  • SM组钙化在诊断性检查中未验证率0.8%(原文写作0.8% vs 10%,按上下文应为SM组0.8%、FFDM/Combo组10%),FFDM/Combo组10%,p<0.0001。
  • SM组钙化诊断性检查时BI-RADS 2/3比例为55%,FFDM/Combo组为42%,p=0.003。
  • 346个(49%)钙化接受活检,其中88个(25%)为恶性;SM组恶性占36%,FFDM/Combo组占22%,OR 0.5(95%CI 0.3-0.8),p=0.01。
  • 622个病灶确立诊断结局,SM组与FFDM/Combo组总体良恶性结局无差异(17% vs 13%,OR 0.8,95%CI 0.5-1.2,p=0.27)。

诊断标准与关键数值

  • 以活检病理或至少1年影像随访作为参考标准确立钙化最终诊断结局(良性或恶性)。
  • 诊断性检查中未验证率SM组0.8% vs FFDM/Combo组10%,p<0.0001。
  • 活检恶性率SM组36% vs FFDM/Combo组22%,OR 0.5(95%CI 0.3-0.8),p=0.01。
  • 总体良恶性结局SM组17% vs FFDM/Combo组13%,OR 0.8(95%CI 0.5-1.2),p=0.27。

临床应用与阅片要点

  • 合成断层融合筛查中因钙化召回时,需注意诊断性检查中未验证率和BI-RADS 2/3分类比例可能高于FFDM/Combo。
  • 活检恶性比例在SM组更高,但最终良恶性结局两组无显著差异。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To compare the outcomes of microcalcifications recalled on full-field digital (FFDM) and FFDM and combined tomosynthesis (Combo) to synthetic (SM) screening mammograms.

METHOD: We reviewed medical records, radiology, and pathology reports of all patients found to have abnormal calcifications requiring further evaluation on mammography screening at our institution between 11/1/2016-11/1/2018 and collected patient demographics, calcification morphology and distribution, and mammography technique (SM, FFDM, or Combo). We used biopsy pathology or at least 1-year imaging follow-up to establish overall diagnostic outcome (benign or malignant). Fisher's exact test was used to compare validation rates at diagnostic work-up, BI-RADS category, and final outcome of calcifications identified on each screening technique. T-test was used for continuous variables.

RESULTS: Of 699 calcifications in 596 women recalled, 176 (30%) of 596 were from SM and 420 (70%) FFDM/Combo. There was a significantly higher rate of calcifications unvalidated at diagnostic work-up for SM compared to FFDM/Combo (0.8% vs. 10%, p < 0.0001). SM calcifications were more likely to receive BI-RADS 2/3 at diagnostic work-up compared to FFDM/Combo ones (55% vs. 42%, p = 0.003). Of 346 (49%) calcifications that underwent biopsy, 88 (25%) were malignant (36% of SM vs. 22% of FFDM/Combo, OR:0.5 [95% CI: 0.3, 0.8] p = 0.01). Of 622 lesions with established diagnostic outcome, there was no difference between having an overall benign or malignant outcome between SM and FFDM/Combo (17% vs. 13%, OR: 0.8 [95% Cl: 0.5, 1.2] p = 0.27).

CONCLUSIONS: Synthetic tomosynthesis screening results in a higher rate of false positive and unvalidated calcification recalls compared to FFDM/Combo.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Zhu H, Polat D, Evans P, et al. Is There a Difference in the Diagnostic Outcomes of Calcifications Initially Identified on Synthetic Tomosynthesis Versus Full-Field Digital Mammography Screening? Eur J Radiol. 2020. PMID: 33142193. doi:10.1016/j.ejrad.2020.109365

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。